References
- Cudkowicz M. E., McKenna‐Yasek D., Sapp P. E., Chin W., Geller B., Hayden D. L., et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 41: 210–21
- Vallee B. L. The function of metallothionein. Neurochem Int 1995; 27: 23–33
- Miles A. T., Hawksworth G. M., Beattie J. H., Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 2000; 35: 35–70
- Montoliu C., Monfort P., Carrasco J., Palacios O., Capdevila M., Hidalgo J., et al. Metallothionein‐III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons. J Neurochem 2000; 75: 266–73
- Ren H., Ji Q., Liu Y., Ru B. Different protective roles in vitro of α‐ and β‐domains of growth inhibitory factor (GIF) on neuron injuries caused by oxygen free radicals. Biochim Biophys Acta 2001; 568: 129–34
- Hozumi I., Asanuma M., Yamada M., Uchida Y. Metallothioneins and neurodegenerative diseases. J Health Science 2004; 50: 323–31
- Uchida Y., Takio K., Titani K., Ihara Y., Tomonaga M. The growth inhibitory factor which is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein‐like protein. Neuron 1991; 7: 337–47
- Quaife C. J., Findley S. D., Froelick J. G., Kelly E. J., Zambrowics B. P., Palmiter R. D. Induction of a new metallothionein isoform (MT‐IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994; 33: 7250–9
- Uchida Y., Gomi F., Masumizu T., Miura Y. Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J Biol Chem 2002; 277: 32353–9
- Nagano S., Satoh M., Sumi H., Fujimura H., Tohyama C., Yanagihara T., et al. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose‐dependent manner. Eur J Neurosci 2001; 13: 1363–70
- Puttaparthi K., Gitomer W. L., Krishnan U., Son M., Rajendran B., Elliott J. L. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non‐neuronal zinc binding proteins. J Neurosci 2002; 22: 8790–6
- Ishigaki S., Niwa J., Ando Y., Yoshihara T., Sawada K., Doyu M., et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords screening by molecular indexing and subsequent cDNA microarray analysis. FEBS lett 2002; 531: 354–8
- Sakamoto T., Kawazoe Y., Uchida Y., Hozumi I., Inuzuka T., Watabe K. Growth inhibitory factor prevents degeneration of injured adult rat motor neurons. NeuroReport 2003; 14: 2147–51
- Kita K., Miura N., Naganuma A. Effect of polymorphism in the promoter of the human gene for metallothionein IIA on its transcription. Seikagaku Abstr 2002; 74: 964, (In Japanese.)
- Brooks B. R., Miller R. G., Swash M., Musat T. L. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–9
- Morahan J. M., Yu B., Trent R. J., Pamphlett R. Screening the metallothionein III gene in sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6: 115–7